vs
Side-by-side financial comparison of CF Industries (CF) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.
CF Industries is the larger business by last-quarter revenue ($1.9B vs $1.4B, roughly 1.4× Option Care Health, Inc.). CF Industries runs the higher net margin — 26.4% vs 3.4%, a 23.1% gap on every dollar of revenue. On growth, CF Industries posted the faster year-over-year revenue change (22.8% vs 1.3%). Over the past eight quarters, CF Industries's revenue compounded faster (12.8% CAGR vs 4.9%).
CF Industries Holdings, Inc. is an American manufacturer and distributor of agricultural fertilizers, including ammonia, urea, and ammonium nitrate products. The company is based in Northbrook, Illinois, a suburb of Chicago, and was founded in 1946 as the Central Farmers Fertilizer Company. For its first 56 years, it was a federation of regional agricultural supply cooperatives. CF then demutualized, and became a publicly traded company.
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
CF vs OPCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.9B | $1.4B |
| Net Profit | $495.0M | $45.3M |
| Gross Margin | 40.9% | 19.4% |
| Operating Margin | 33.0% | 5.4% |
| Net Margin | 26.4% | 3.4% |
| Revenue YoY | 22.8% | 1.3% |
| Net Profit YoY | 26.3% | -3.0% |
| EPS (diluted) | $2.56 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.9B | $1.4B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.6B | $1.2B |
| Q1 26 | — | $45.3M | ||
| Q4 25 | $495.0M | $58.5M | ||
| Q3 25 | $460.0M | $51.8M | ||
| Q2 25 | $492.0M | $50.5M | ||
| Q1 25 | $351.0M | $46.7M | ||
| Q4 24 | $392.0M | $60.1M | ||
| Q3 24 | $341.0M | $53.9M | ||
| Q2 24 | $506.0M | $53.0M |
| Q1 26 | — | 19.4% | ||
| Q4 25 | 40.9% | 19.3% | ||
| Q3 25 | 38.1% | 19.0% | ||
| Q2 25 | 39.9% | 19.0% | ||
| Q1 25 | 34.4% | 19.7% | ||
| Q4 24 | 34.4% | 21.3% | ||
| Q3 24 | 32.4% | 20.1% | ||
| Q2 24 | 43.2% | 20.3% |
| Q1 26 | — | 5.4% | ||
| Q4 25 | 33.0% | 6.2% | ||
| Q3 25 | 35.0% | 5.9% | ||
| Q2 25 | 34.3% | 5.8% | ||
| Q1 25 | 27.4% | 5.9% | ||
| Q4 24 | 28.9% | 6.9% | ||
| Q3 24 | 26.6% | 6.7% | ||
| Q2 24 | 40.6% | 6.6% |
| Q1 26 | — | 3.4% | ||
| Q4 25 | 26.4% | 4.0% | ||
| Q3 25 | 27.7% | 3.6% | ||
| Q2 25 | 26.0% | 3.6% | ||
| Q1 25 | 21.1% | 3.5% | ||
| Q4 24 | 25.7% | 4.8% | ||
| Q3 24 | 24.9% | 4.2% | ||
| Q2 24 | 32.2% | 4.3% |
| Q1 26 | — | $0.29 | ||
| Q4 25 | $2.56 | $0.37 | ||
| Q3 25 | $2.19 | $0.32 | ||
| Q2 25 | $2.37 | $0.31 | ||
| Q1 25 | $1.85 | $0.28 | ||
| Q4 24 | $1.86 | $0.36 | ||
| Q3 24 | $1.55 | $0.31 | ||
| Q2 24 | $2.30 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $177.3M |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $4.8B | — |
| Total Assets | $14.1B | $3.4B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $177.3M | ||
| Q4 25 | — | $232.6M | ||
| Q3 25 | — | $309.8M | ||
| Q2 25 | — | $198.8M | ||
| Q1 25 | — | $171.4M | ||
| Q4 24 | — | $412.6M | ||
| Q3 24 | — | $483.0M | ||
| Q2 24 | — | $376.9M |
| Q1 26 | — | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.0B | $1.2B | ||
| Q2 25 | $3.0B | $1.1B | ||
| Q1 25 | $3.0B | $1.1B | ||
| Q4 24 | $3.0B | $1.1B | ||
| Q3 24 | $3.0B | $1.1B | ||
| Q2 24 | $3.0B | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | $4.8B | $1.3B | ||
| Q3 25 | $4.8B | $1.4B | ||
| Q2 25 | $5.0B | $1.4B | ||
| Q1 25 | $4.8B | $1.4B | ||
| Q4 24 | $5.0B | $1.4B | ||
| Q3 24 | $5.2B | $1.4B | ||
| Q2 24 | $5.5B | $1.4B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $14.1B | $3.5B | ||
| Q3 25 | $14.2B | $3.5B | ||
| Q2 25 | $13.8B | $3.4B | ||
| Q1 25 | $13.3B | $3.3B | ||
| Q4 24 | $13.5B | $3.4B | ||
| Q3 24 | $13.8B | $3.4B | ||
| Q2 24 | $13.8B | $3.3B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.61× | 0.86× | ||
| Q2 25 | 0.60× | 0.82× | ||
| Q1 25 | 0.62× | 0.82× | ||
| Q4 24 | 0.60× | 0.79× | ||
| Q3 24 | 0.57× | 0.78× | ||
| Q2 24 | 0.54× | 0.79× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $539.0M | — |
| Free Cash FlowOCF − Capex | $313.0M | — |
| FCF MarginFCF / Revenue | 16.7% | — |
| Capex IntensityCapex / Revenue | 12.1% | — |
| Cash ConversionOCF / Net Profit | 1.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.8B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $539.0M | $258.4M | ||
| Q3 25 | $1.1B | $139.4M | ||
| Q2 25 | $563.0M | $90.3M | ||
| Q1 25 | $586.0M | $-7.2M | ||
| Q4 24 | $420.0M | $36.1M | ||
| Q3 24 | $931.0M | $160.4M | ||
| Q2 24 | $475.0M | $195.7M |
| Q1 26 | — | — | ||
| Q4 25 | $313.0M | — | ||
| Q3 25 | $717.0M | $130.2M | ||
| Q2 25 | $318.0M | $81.2M | ||
| Q1 25 | $454.0M | $-16.6M | ||
| Q4 24 | $223.0M | $25.8M | ||
| Q3 24 | $792.0M | $150.7M | ||
| Q2 24 | $391.0M | $185.9M |
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | — | ||
| Q3 25 | 43.2% | 9.1% | ||
| Q2 25 | 16.8% | 5.7% | ||
| Q1 25 | 27.3% | -1.2% | ||
| Q4 24 | 14.6% | 2.0% | ||
| Q3 24 | 57.8% | 11.8% | ||
| Q2 24 | 24.9% | 15.1% |
| Q1 26 | — | — | ||
| Q4 25 | 12.1% | — | ||
| Q3 25 | 20.9% | 0.6% | ||
| Q2 25 | 13.0% | 0.6% | ||
| Q1 25 | 7.9% | 0.7% | ||
| Q4 24 | 12.9% | 0.8% | ||
| Q3 24 | 10.1% | 0.8% | ||
| Q2 24 | 5.3% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.09× | 4.42× | ||
| Q3 25 | 2.31× | 2.69× | ||
| Q2 25 | 1.14× | 1.79× | ||
| Q1 25 | 1.67× | -0.15× | ||
| Q4 24 | 1.07× | 0.60× | ||
| Q3 24 | 2.73× | 2.98× | ||
| Q2 24 | 0.94× | 3.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CF
| Ammonia | $591.0M | 32% |
| UAN | $493.0M | 26% |
| Urea | $372.0M | 20% |
| Other | $244.0M | 13% |
| Other Products | $147.0M | 8% |
| Ammonium Nitrate Segment | $25.0M | 1% |
OPCH
Segment breakdown not available.
